Brief: Bml Investment Partners Lp Reports 19.4% Passive Stake In Satsuma Pharmaceuticals Inc As Of November 14 - SEC Filing
16/11/2022 23:33
Satsuma Pharmaceuticals Inc STSA.O :
* BML INVESTMENT PARTNERS LP REPORTS 19.4% PASSIVE STAKE IN
SATSUMA PHARMACEUTICALS INC AS OF NOVEMBER 14 - SEC FILING
Source text for Eikon: ID:
Further company coverage: STSA.O
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon